BioCryst Pharmaceuticals shares owned by Tower Research Capital
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $95k | 13k | 7.60 |
| 2024-06-30 | $350k | 57k | 6.18 |
| 2024-03-31 | $18k | 3.6k | 5.08 |
| 2023-09-30 | $32k | 4.5k | 7.08 |
| 2023-06-30 | $166k | 24k | 7.04 |
| 2023-03-31 | $98k | 12k | 8.31 |
| 2022-12-31 | $186k | 16k | 11.49 |
| 2022-09-30 | $589k | 47k | 12.60 |
| 2022-06-30 | $389k | 36k | 10.83 |
| 2022-03-31 | $263k | 16k | 16.27 |
| 2021-12-31 | $344k | 25k | 13.85 |
| 2021-09-30 | $560k | 39k | 14.39 |
| 2021-06-30 | $308k | 20k | 15.83 |
| 2021-03-31 | $622k | 61k | 10.18 |
| 2020-12-31 | $473k | 64k | 7.40 |
| 2020-09-30 | $1.5M | 444k | 3.44 |
| 2020-06-30 | $479k | 101k | 4.77 |
| 2019-03-31 | $3.0k | 353 | 8.50 |
| 2017-12-31 | $1.0k | 304 | 3.29 |
| 2017-09-30 | $57k | 9.4k | 5.99 |
| 2017-06-30 | $3.0k | 600 | 5.00 |
| 2016-12-31 | $43k | 7.2k | 6.00 |
| 2016-09-30 | $2.0k | 449 | 4.45 |
| 2016-06-30 | $7.0k | 2.4k | 2.90 |
| 2015-12-31 | $44k | 4.2k | 10.38 |
| 2015-06-30 | $72k | 4.7k | 15.50 |
| 2015-03-31 | $78k | 7.8k | 10.05 |
| 2014-12-31 | $31k | 2.6k | 12.01 |
| 2014-09-30 | $18k | 1.8k | 9.79 |
| 2014-06-30 | $212k | 16k | 13.11 |
| 2014-03-31 | $13k | 1.2k | 10.55 |
| 2013-12-31 | $6.0k | 768 | 7.81 |
| 2013-09-30 | $114k | 16k | 7.29 |
| 2013-06-30 | $18k | 12k | 1.55 |